Crossref
journal-article
Elsevier BV
European Journal of Pharmacology (78)
References
50
Referenced
81
10.1016/S0014-2999(03)01557-7
/ Eur. J. Pharmacol. / Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons by Basavarajappa (2003)10.1126/science.277.5329.1094
/ Science / Functional role of high-affinity anandamide transport, as revealed by selective inhibition by Beltramo (1997)10.1074/jbc.272.6.3315
/ J. Biol. Chem. / Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes by Bisogno (1997)10.1046/j.1432-1327.2001.02072.x
/ Eur. J. Biochem. / The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors by Bisogno (2001)10.1053/jhep.2003.50459
/ Hepatology / Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis by Biswas (2003)10.1023/A:1022413901857
/ Neurochem. Res. / Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes by Bloom (1997)10.1194/jlr.M300170-JLR200
/ J. Lipid Res. / Binding of anandamide to bovine serum albumin by Bojesen (2003)10.1016/0929-7855(96)00510-X
/ J. Lipid Mediators Cell Signal. / Membrane localization of N-acylphosphatidylethanolamine in central neurons: studies with exogenous phospholipases by Cadas (1996)10.1016/S1056-8719(01)00148-4
/ J. Pharmacol. Toxicol. Methods / AM-404 elevates renal intracellular Ca2+, questioning its selectivity as a pharmacological tool for investigating the anandamide transporter by Chen (2001)10.1124/mol.59.6.1369
/ Mol. Pharmacol. / Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide by Day (2001)10.1016/S0014-5793(00)02082-2
/ FEBS Lett. / Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity by De Petrocellis (2000)10.1016/S0014-5793(01)02934-9
/ FEBS Lett. / Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors by De Petrocellis (2001)10.1016/0006-2952(93)90486-G
/ Biochem. Pharmacol. / Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist by Deutsch (1993)10.1074/jbc.M003161200
/ J. Biol. Chem. / The cellular uptake of anandamide is coupled to its breakdown by fatty acid amide hydrolase (FAAH) by Deutsch (2001)10.1038/372686a0
/ Nature / Formation and inactivation of endogenous cannabinoid anandamide in central neurons by Di Marzo (1994)10.1006/bbrc.2001.4354
/ Biochem. Biophys. Res. Commun. / Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor “hybrid” ligands by Di Marzo (2001)10.1046/j.1432-1033.2003.03724.x
/ Eur. J. Biochem. / Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? by Fasia (2003)10.1111/j.1471-4159.1990.tb08845.x
/ J. Neurochem. / Reduction in beta-adrenoceptor density in cultured rat glioma C6 cells after incubation with antidepressants is dependent upon the culturing conditions used by Fowler (1990)-
Karlsson, M., Påhlsson, C.,Fowler, C.J., Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments. Eur. J. Pharm. Sci., in press.
(
10.1016/j.ejps.2004.03.009
) 10.1016/S0006-2952(01)00712-2
/ Biochem. Pharmacol. / Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide by Fowler (2001)10.1080/1475636021000049726
/ J. Enzyme Inhib. Med. Chem. / Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner by Fowler (2003)10.1073/pnas.0730816100
/ Proc. Natl. Acad. Sci. U. S. A. / Evidence against the presence of an anandamide transporter by Glaser (2003)10.1002/jnr.490330213
/ J. Neurosci. Res. / Altered genetic response to beta-adrenergic receptor activation in late passage C6 glioma cells by Gubits (1992)10.1016/0003-2697(90)90081-J
/ Anal. Biochem. / Lowry protein assay containing sodium dodecyl sulfate in microtiter plates for protein determination on fractions from brain tissue by Harrington (1990)10.1016/S0009-3084(00)00191-2
/ Chem. Phys. Lipids / The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes by Hillard (2000)10.1038/sj.bjp.0705468
/ Br. J. Pharmacol. / Cellular accumulation of anandamide: consensus and controversy by Hillard (2003)10.1016/0005-2760(95)00087-S
/ Biochim. Biophys. Acta / Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain by Hillard (1995)10.1046/j.1471-4159.1997.69020631.x
/ J. Neurochem. / Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion by Hillard (1997)10.1007/s00210-002-0686-z
/ Naunyn-Schmiedeberg's Arch. Pharmacol. / Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra—but not intracellular pH by Holt (2003)10.1038/sj.bjp.0704113
/ Br. J. Pharmacol. / Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen by Holt (2001)10.1038/sj.bjp.0704029
/ Br. J. Pharmacol. / Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide by Jacobsson (2001){'key': '10.1016/j.ejphar.2004.03.048_BIB51', 'first-page': '951', 'article-title': 'Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors', 'volume': '299', 'author': 'Jacobsson', 'year': '2001', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. / Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors by Jacobsson (2001)10.1046/j.1471-4159.2000.0742597.x
/ J. Neurochem. / Structure–activity relationships among N-arachidonoylethanolamine (anandamide) head group analogues for the anandamide transported by Jarrahian (2000)10.1038/sj.bjp.0704199
/ Br. J. Pharmacol. / Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide by Jonsson (2001)10.1007/s00204-002-0435-6
/ Arch. Toxicol. / AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide by Jonsson (2003)10.1038/nm803
/ Nat. Med. / Modulation of anxiety through blockade of anandamide hydrolysis by Kathuria (2003)10.1042/bj20031812
/ Biochem. J. / Further evidence for the existence of a specific process for the membrane transport of anandamide by Ligresti (2004)10.1021/jm0210818
/ J. Med. Chem. / Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors: comparison with effects upon fatty acid amidohydrolase by López-Rodrı́guez (2003)10.1016/0014-5793(95)01311-3
/ FEBS Lett. / Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’ by Maurelli (1995){'key': '10.1016/j.ejphar.2004.03.048_BIB40', 'article-title': 'Uptake of the endogenous cannabinoid anandamide by endocytic processes and accumulation in lipid rafts', 'author': 'McFarland', 'year': '2003', 'journal-title': 'Exp. Biol.'}
/ Exp. Biol. / Uptake of the endogenous cannabinoid anandamide by endocytic processes and accumulation in lipid rafts by McFarland (2003)10.1074/jbc.M306642200
/ J. Biol. Chem. / Molecular characterization of a phospholipase D generating anandamide and its congeners by Okamoto (2004)10.1016/0024-3205(95)00181-5
/ Life Sci. / Arachidonyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase by Omeir (1995)10.1016/S0006-2952(03)00109-6
/ Biochem. Pharmacol. / Novel selective and metabolically stable inhibitors of anandamide cellular uptake by Ortar (2003){'key': '10.1016/j.ejphar.2004.03.048_BIB44', 'first-page': '960', 'article-title': 'Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells', 'volume': '292', 'author': 'Rakhshan', 'year': '2000', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. / Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells by Rakhshan (2000)10.1038/sj.bjp.0705628
/ Br. J. Pharmacol. / Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study by Ruiz-Llorente (2004)10.1007/s00018-003-3055-2
/ Cell. Mol. Life Sci. / Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts by Sarker (2003)10.1016/S0021-9258(17)44667-9
/ J. Biol. Chem. / Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type by Schmid (1983)10.1016/S0021-9258(17)38695-7
/ J. Biol. Chem. / Properties of rat liver N-acylethanolamine amidohydrolase by Schmid (1985)10.1021/jm0209679
/ J. Med. Chem. / Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide by Vandevoorde (2003)10.1016/S0003-2697(03)00217-3
/ Anal. Biochem. / A high-throughput-compatible assay for determining the activity of fatty acid amide hydrolase by Wilson (2003)
Dates
Type | When |
---|---|
Created | 21 years, 3 months ago (May 15, 2004, 6:35 a.m.) |
Deposited | 4 years, 2 months ago (June 17, 2021, 12:27 p.m.) |
Indexed | 5 months, 2 weeks ago (March 19, 2025, 12:56 p.m.) |
Issued | 21 years, 4 months ago (May 1, 2004) |
Published | 21 years, 4 months ago (May 1, 2004) |
Published Print | 21 years, 4 months ago (May 1, 2004) |
@article{Fowler_2004, title={Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis—a difficult issue to handle}, volume={492}, ISSN={0014-2999}, url={http://dx.doi.org/10.1016/j.ejphar.2004.03.048}, DOI={10.1016/j.ejphar.2004.03.048}, number={1}, journal={European Journal of Pharmacology}, publisher={Elsevier BV}, author={Fowler, Christopher J and Tiger, Gunnar and Ligresti, Alessia and López-Rodrı́guez, Marı́a L and Di Marzo, Vincenzo}, year={2004}, month=may, pages={1–11} }